 |
|
HTLV-III/LAV Infection in Hemodialysis Patients
Thomas A. Peterman, MD, MSc;
Gordon R. Lang, MD;
Norine J. Mikos, RN;
Steven L. Solomon, MD;
Charles A. Schable, MS;
Paul M. Feorino, PhD;
Judith A. Britz, PhD;
James R. Allen, MD, MPH
JAMA. 1986;255(17):2324-2326.
Abstract
Twenty-five (4.8%) of 520 hemodialysis patients were seropositive for antibody to human T-cell lymphotropic virus type III lymphadenopathyassociated virus (HTLV-III/LAV) by enzyme immunoassay. Four had high reactivity on enzyme immunoassay and positive results of Western blot tests, and one of the four had a positive culture. The remaining 21 seropositive patients had low reactivity on enzyme immunoassay, negative results of Western blot tests, and negative cultures. All had received blood transfusions and 19 had antibodies to antigens associated with the H9 cell line used to propagate HTLV-III for serological tests. We found that HTLV-III/LAV was not transmitted in the dialysis centers. Frequent blood transfusion places dialysis patients at risk for HTLV-III/LAV infection, but may more commonly lead to false-positive results of enzyme immunoassay tests.
(JAMA 1986;255:2324-2326)
Author Affiliations
From the AIDS Branch, Division of Viral Diseases (Drs Peterman, Feorino, and Allen and Mr Schable), and the Hospital Infections Program (Dr Solomon), Center for Infectious Diseases, Centers for Disease Control, Atlanta; the Neomedica Dialysis Centers, Chicago (Dr Lang and Ms Mikos); and Electro-Nucleonics Inc, Columbia, Md (Dr Britz).
Footnotes
Reprint requests to AIDS Branch, Centers for Disease Control, Atlanta, GA 30333 (Dr Peterman).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Risk and Management of Blood-Borne Infections in Health Care Workers
Beltrami et al.
Clin. Microbiol. Rev. 2000;13:385-407.
ABSTRACT
| FULL TEXT
Human Immunodeficiency Virus (HIV) Infection and the Kidney
Glassock et al.
ANN INTERN MED 1990;112:35-49.
ABSTRACT
Human Immunodeficiency Virus Infection in Hemodialysis Patients
Baltimore-Boston Collaborative Study Group et al.
Arch Intern Med 1988;148:617-619.
ABSTRACT
Transfusion and Long-term Hemodialysis
Crowley et al.
Arch Intern Med 1987;147:1925-1928.
ABSTRACT
Acquired Immunodeficiency Syndrome in Low-Incidence Areas: How Safe Is Unsafe Sex?
Fleming et al.
JAMA 1987;258:785-787.
ABSTRACT
Acute Renal Failure in Critically Ill Patients
Ellison and Bia
J Intensive Care Med 1987;2:8-24.
ABSTRACT
Screening for HIV Infection: Risks, Benefits, and the Burden of Proof
Barry et al.
J Law Med Ethics 1986;14:259-267.
Prevalence of Human Immunodeficiency Virus Antibodies and Hepatitis B Markers Among Patients Having Hemodialysis
VILLANUEVA et al.
ANN INTERN MED 1986;105:967-968.
ABSTRACT
Recommendations for Providing Dialysis Treatment to Patients Infected with Human T-Lymphotropic Virus Type lll/Lymphadenopathy-Associated Virus
ANN INTERN MED 1986;105:558-559.
ABSTRACT
Leads from the MMWR
JAMA 1986;256:697-704.
|
